Skip to content

Clinical trial of vagus nerve stimulation for treatment of refractory epilepsy

The clinical research on TsingHua vagus nerve stimualtor for treatment of refractory epilepsy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14005138
Enrollment
Unknown
Registered
2014-08-06
Start date
2014-08-11
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory Epilepsy

Interventions

experimental group:On
contral group:Off

Sponsors

Beijing Tiantan Hopital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. age 6-60; 2. Having tried at least two appropriate anti-epileptic drugs (AEDs) tested to tolerance or to blood levels at upper end of the target range of which at least 2 have been tolerated at normal dose; 3. at least 6 seizures per month; 4. in good health except epilepsy; 5. to with normal MMSE score; 6. patients or his(her) familyscould understand this method and sign the informed consent; 7. Patients with good compliance and could complete postoperative follow-up.

Exclusion criteria

Exclusion criteria: 1. results of MRI remind epilepsy caused by intracranial space-occupying lesions; 2. The vagus nerve lesion and damage; 3. Tumor, cardiopulmonary anomaly, progressive neurological diseases, asthma, mental disease, peptic ulcer, diabetes Type 1, bad health etc, and other surgical contraindication.

Design outcomes

Primary

MeasureTime frame
electroencephalogram;

Countries

China

Contacts

Public ContactJianguo Zhang
zjguo73@126.com+86 13601294613

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026